FilingSEC EDGAR6-K
Psyence Biomedical Establishes Subsidiary for U.S. Ibogaine Development
· SEC accepted
StageEarly Stage
Filing content
Psyence Biomedical established Texas Ibogaine Research Corporation to coordinate U.S. ibogaine development, supply, and regulatory engagement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…